Africa: HIV Vaccine Research Set to Change Focus in Wake of Mosaico Disappointment ...Middle East

allafrica - Economy
Africa: HIV Vaccine Research Set to Change Focus in Wake of Mosaico Disappointment
[spotlight] Hopes for the Johnson & Johnson (J&J) Mosaico vaccine - the only HIV vaccine candidate in late-stage (Phase 3) clinical trials - were dashed with manufacturer Janssen Pharmaceuticals' recent announcement that the vaccine lacked efficacy in preventing HIV infection. In the wake of this announcement, top South African HIV clinicians are now setting their sights on different approaches to finding an HIV vaccine.

Hence then, the article about africa hiv vaccine research set to change focus in wake of mosaico disappointment was published today ( ) and is available on allafrica ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Africa: HIV Vaccine Research Set to Change Focus in Wake of Mosaico Disappointment )

Apple Storegoogle play

Last updated :

Also on site :